Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Mar 2:372:n355.
doi: 10.1136/bmj.n355.

High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trial

Ralph A H Stewart  1   2 , Peter Jones  3   4 , Bridget Dicker  5 , Yannan Jiang  6 , Tony Smith  7 , Andrew Swain  8 , Andrew Kerr  9   10 , Tony Scott  11 , David Smyth  12 , Anil Ranchord  13 , John Edmond  14 , Martin Than  15 , Mark Webster  16   2 , Harvey D White  16   2 , Gerard Devlin  17
Affiliations
Randomized Controlled Trial

High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trial

Ralph A H Stewart et al. BMJ. .

Abstract

Objective: To determine the association between high flow supplementary oxygen and 30 day mortality in patients presenting with a suspected acute coronary syndrome (ACS).

Design: Pragmatic, cluster randomised, crossover trial.

Setting: Four geographical regions in New Zealand.

Participants: 40 872 patients with suspected or confirmed ACS included in the All New Zealand Acute Coronary Syndrome Quality Improvement registry or ambulance ACS pathway during the study periods. 20 304 patients were managed using the high oxygen protocol and 20 568 were managed using the low oxygen protocol. Final diagnosis of ST elevation myocardial infarction (STEMI) and non-STEMI were determined from the registry and ICD-10 discharge codes.

Interventions: The four geographical regions were randomly allocated to each of two oxygen protocols in six month blocks over two years. The high oxygen protocol recommended oxygen at 6-8 L/min by face mask for ischaemic symptoms or electrocardiographic changes, irrespective of the transcapillary oxygen saturation (SpO2). The low oxygen protocol recommended oxygen only if SpO2 was less than 90%, with a target SpO2 of less than 95%.

Main outcome measure: 30 day all cause mortality determined from linkage to administrative data.

Results: Personal and clinical characteristics of patients managed under both oxygen protocols were well matched. For patients with suspected ACS, 30 day mortality for the high and low oxygen groups was 613 (3.0%) and 642 (3.1%), respectively (odds ratio 0.97, 95% confidence interval 0.86 to 1.08). For 4159 (10%) patients with STEMI, 30 day mortality for the high and low oxygen groups was 8.8% (n=178) and 10.6% (n=225), respectively (0.81, 0.66 to 1.00) and for 10 218 (25%) patients with non-STEMI was 3.6% (n=187) and 3.5% (n=176), respectively (1.05, 0.85 to 1.29).

Conclusion: In a large patient cohort presenting with suspected ACS, high flow oxygen was not associated with an increase or decrease in 30 day mortality.

Trial registration: ANZ Clinical Trials ACTRN12616000461493.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the National Heart Foundation of New Zealand (grant No 1649) and from the Health Research Council of New Zealand clinical practitioner fellowships to RAHS and MT; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years ; no other relationships or activities that could appear to have influenced the submitted work.

Figures

Fig 1
Fig 1
Study flow diagram. ACS=acute coronary syndrome; ANZACS-QI=All New Zealand Acute Coronary Syndrome Quality Improvement registry
Fig 2
Fig 2
Kaplan-Meier plot showing all cause mortality for New Zealand patients with suspected acute coronary syndrome (ACS) managed on high and low oxygen protocols. All cause mortality was determined from national administrative data assessed on 12 August 2019 for all patients. The length of follow-up after one year varied according to the date of first assessment of ACS during the study
See this image and copyright information in PMC

References

    1. Beasley R, Aldington S, Weatherall M, Robinson G, McHaffie D. Oxygen therapy in myocardial infarction: an historical perspective. J R Soc Med 2007;100:130-3. 10.1177/014107680710000311 - DOI - PMC - PubMed
    1. McNulty PH, King N, Scott S, et al. Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization. Am J Physiol Heart Circ Physiol 2005;288:H1057-62. 10.1152/ajpheart.00625.2004 - DOI - PubMed
    1. Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet 2018;391:1693-705. 10.1016/S0140-6736(18)30479-3 - DOI - PubMed
    1. Hofmann R, James SK, Jernberg T, et al. DETO2X–SWEDEHEART Investigators . Oxygen Therapy in Suspected Acute Myocardial Infarction. N Engl J Med 2017;377:1240-9. 10.1056/NEJMoa1706222 - DOI - PubMed
    1. Amsterdam EA, Wenger NK, Brindis RG, et al. ACC/AHA Task Force Members. Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons . 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. [correction in: Circulation 2014;130:e431-2.] Circulation 2014;130:2354-94. 10.1161/CIR.0000000000000133 - DOI - PubMed

Publication types